CD8A and neoplasm: It is tempting to speculate that the inverse prognostic impact of tumor-infiltrating lymphocytes in RCC is evidence for particularly efficient anti-immune mechanisms in these tumors protecting RCC cells from CD8+ cytotoxic T cells.